Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rich, M. M.
Right arrow Articles by Lichtman, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rich, M. M.
Right arrow Articles by Lichtman, J. W.
NEUROLOGY 1994;44:2138
© 1994 American Academy of Neurology

In vivo imaging shows loss of synaptic sites from neuromuscular junctions in a model of myasthenia gravis

Mark M. Rich, MD, PhD, Howard Colman, BSc and Jeff W. Lichtman, MD, PhD

Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, MO.

We examined the pre- and postsynaptic elements of the neuromuscular junction during immune attack on the postsynaptic acetylcholine receptors (AChRs) in a model of myasthenia gravis (MG). We followed, in the sternomastoid muscle of living mice, the staining of nerve terminals and postsynaptic AChRs at individual neuromuscular junctions in situ for up to 16 days after exposure to a monoclonal anti-AChR antibody. Several exposures to this antibody over 6 days led to spotty loss of AChR staining 1 to 3 days later within individual neuromuscular junctions. In addition, we observed loss of motor nerve terminal staining at presynaptic sites opposed to postsynaptic regions that had lost AChRs. Sites that lost pre- and postsynaptic staining were often immediately adjacent to other junctional regions that maintained a high density of AChRs and still stained presynaptically. Ultimately, the loss of synaptic sites resulted in neuromuscular junctions that appeared to be abnormally fragmented. To determine whether junctions recovered from the immune attack, we followed some antibody-treated muscle fibers for an additional 8 days without further exposure to antibody. Signs of recovery were evident because some of the synaptic regions that had previously lost AChRs subsequently regained them. But these junctions still remained fragmented both pre- and postsynaptically. These findings suggest that the postsynaptic membrane is affected in a highly local way by the immune attack on AChRs occurring in MG. One consequence of this attack is a long-term loss of not only postsynaptic components but also the overlying nerve terminals.

Address correspondence and reprint requests to Dr. Mark M. Rich, Department of Neurology, 3 West Gates Building, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104-4283.

This work was supported by grants from the National Institutes of Health and Muscular Dystrophy Association to J.W. Lichtman. H. Colman was supported by a Medical Scientist Training Program Grant from the NIH.

Received March 16,1994. Accepted in final form May 23,1994.




This article has been cited by other articles:


Home page
NeuroscientistHome page
M. M. Rich
The Control of Neuromuscular Transmission in Health and Disease
Neuroscientist, April 1, 2006; 12(2): 134 - 142.
[Abstract] [PDF]


Home page
J. Physiol.Home page
T. H Gillingwater and R. R Ribchester
Compartmental neurodegeneration and synaptic plasticity in the Wlds mutant mouse
J. Physiol., August 1, 2001; 534(3): 627 - 639.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.